Advertisement

Topics

Interview: PharmAbcine's Hopes Rise As Tanibirumab Set For Keytruda Combo Trials

22:06 EDT 2 Sep 2018 | SCRIP

PharmAbcine CEO Jin-San Yoo talks to Scrip about the company’s overseas clinical trial strategy, pipeline assets, and ambitions for lead...

      

Related Stories

 

Original Article: Interview: PharmAbcine's Hopes Rise As Tanibirumab Set For Keytruda Combo Trials

NEXT ARTICLE

More From BioPortfolio on "Interview: PharmAbcine's Hopes Rise As Tanibirumab Set For Keytruda Combo Trials"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...